Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Khorinko, A."'
Autor:
Sergey M. Alexeev, Andrey V. Khorinko, Guzel Z. Mukhametshina, Konstantin G. Shelepen, Olga N. Burdaeva, Sergey A. Kulik, Chiradoni Thugappa Satheesh, Kirti Srivastava, Mummaneni Vikranth, Fedor Kryukov, Anastasia N. Paltusova, Mariya S. Shustova, Roman A. Ivanov
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background BCD-022 is a trastuzumab biosimilar which was shown to be equivalent to reference trastuzumab in a wide panel of physicochemical studies as well as preclinical studies in vitro and in vivo. International multicenter phase III clin
Externí odkaz:
https://doaj.org/article/91e85db418314c6180848ec4b818e417
Autor:
E O Ignatova, O N Burdaeva, M V Kopp, B N Kotiv, D P Udovitsa, D L Stroiakovskii, S M Alekseev, L P Sheveleva, A V Khorinko, Iu S Shapovalova, V M Moiseenko, R A Ivanov
Publikováno v:
Современная онкология, Vol 18, Iss 2, Pp 39-47 (2016)
Objective. Within the multi-center double-blind randomized clinical study, investigate the bioequivalence (immediate efficacy, safety and pharmacokinetics) of BCD-022 (trastuzumab, JSC BIOCAD, Russia), as compared with Herceptin® (trastuzumab, F.Hof
Externí odkaz:
https://doaj.org/article/a2ddfb29e90a4971a38b8f7e9b03b151
Autor:
Della-Fiorentina, S., Begbie, S., Jennens, R., Dass, J., Pittman, K., Ivanova, N., Koynova, T., Petrov, P., Tomova, A., Tzekova, V., Couture, F., Hirsh, V., Burkes, R., Sangha, R., Ambrus, M., Janaskova, T., Musil, J., Novotny, J., Zatloukal, P., Jakesova, J., Klenha, K., Roubec, J., Vanasek, J., Fayette, J., Barlesi, F., Bennouna-Louridi, J., Chouaid, C., Mazières, J., Vallerand, H., Robinet, G., Souquet, P.-J., Spaeth, D., Schott, R., Lena, H., Martinet, Y., El Kouri, C., Baize, N., Scherpereel, A., Molinier, O., Fuchs, F., Josten, K.M., Manegold, C., Marschner, N., Schneller, F., Overbeck, T., Thomas, M., von Pawel, J., Reck, M., Schuette, W., Hagen, V., Schneider, C.-P., Georgoulias, V., Varthalitis, I., Zarogoulidis, K., Syrigos, K., Papandreou, C., Bocskei, C., Csanky, E., Juhasz, E., Losonczy, G., Mark, Z., Molnar, I., Papai-Szekely, Z., Tehenes, S., Vinkler, I., Almel, S., Bakshi, A., Bondarde, S., Maru, A., Pathak, A., Pedapenki, R.M., Prasad, K., Prasad, S.V.S.S., Kilara, N., Gorijavolu, D., Deshmukh, C.D., John, S., Sharma, L.M., Amoroso, D., Bajetta, E., Bidoli, P., Bonetti, A., De Marinis, F., Maio, M., Passalacqua, R., Cascinu, S., Bearz, A., Bitina, M., Brize, A., Purkalne, G., Skrodele, M., Baba, A.A., Ratnavelu, K., Saw, M.H., Samson-Fernando, M.C., Ladrera, G.E., Jassem, J., Koralewski, P., Serwatowski, P., Krzakowski, M., Cebotaru, C., Filip, D., Ganea-Motan, D.E., Ianuli, C.H., Manolescu, I.G., Udrea, A., Burdaeva, O., Byakhov, M., Filippov, A., Lazarev, S., Mosin, I., Orlov, S., Udovitsa, D., Khorinko, A., Protsenko, S., Chang, A., Lim, H.L., Tan, Y.O., Tan, E.H., Bastus Piulats, R., Garcia-Foncillas, J., Valdivia, J., de Castro, J., Domine Gomez, M., Kim, S.W., Lee, J.-S., Kim, H.K., Lee, J.S., Shin, S.W., Kim, D.-W., Kim, Y.-C., Park, K.C., Chang, C.-S., Chang, G.-C., Goan, Y.-G., Su, W.-C., Tsai, C.-M., Kuo, H.-P., Benekli, M., Demir, G., Gokmen, E., Sevinc, A., Crawford, J., Giaccone, G., Haigentz, M., Owonikoko, T., Agarwal, M., Pandit, S., Araujo, R., Vrindavanam, N., Bonomi, P., Berg, A., Wade, J., Bloom, R., Amin, B., Camidge, R., Hill, D., Rarick, M., Flynn, P., Klein, L., Lo Russo, K., Neubauer, M., Richards, P., Ruxer, R., Savin, M., Weckstein, D., Rosenberg, R., Whittaker, T., Richards, D., Berry, W., Ottensmeier, C., Dangoor, A., Steele, N., Summers, Y., Rankin, E., Rowley, K., Giridharan, S., Kristeleit, H., Humber, C., Taylor, P., Ramalingam, S., Perez-Soler, R., Douillard, J.-Y., Thatcher, N., Wang, Y., Pultar, P., Zhu, J., Malik, R.
Publikováno v:
In Annals of Oncology November 2013 24(11):2875-2880
Autor:
Konstantin G. Shelepen, Anastasia N. Paltusova, Fedor Kryukov, Sergey M. Alexeev, Mariya S. Shustova, Sergey A. Kulik, Kirti Srivastava, Chiradoni Thugappa Satheesh, Olga Burdaeva, Guzel Z. Mukhametshina, Andrey V. Khorinko, Roman Ivanov, Mummaneni Vikranth
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background BCD-022 is a trastuzumab biosimilar which was shown to be equivalent to reference trastuzumab in a wide panel of physicochemical studies as well as preclinical studies in vitro and in vivo. International multicenter phase III clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e583dc70946efde96993e08fa512bc31
https://doi.org/10.1186/s12885-020-07247-9
https://doi.org/10.1186/s12885-020-07247-9
Autor:
Alexeev, Sergey M., Khorinko, Andrey V., Mukhametshina, Guzel Z., Shelepen, Konstantin G., Burdaeva, Olga N., Kulik, Sergey A., Chiradoni Thugappa Satheesh, Srivastava, Kirti, Mummaneni Vikranth, Kryukov, Fedor, Paltusova, Anastasia N., Shustova, Mariya S., Ivanov, Roman A.
Additional file 1: Supplemental Table 1. Characteristics of the main disease in patients involved in the study (ITT population) by groups.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0609d215ca3a9bf3c8d535827a5e8886
Autor:
Vitaliy P. Khorinko, Dmitriy G. Amarantov, Marina O. Karipova, Andrei V. Khorinko, Pauline V. Kosareva
Publikováno v:
Journal of Ural Medical Academic Science. :10-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e1ec7d069543ce9b4a1ecf9f7026afd
https://doi.org/10.22138/2500-0918-2016-14-4-10-16
https://doi.org/10.22138/2500-0918-2016-14-4-10-16
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Anatomy and Histopathology. 5:84-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb15bade83f9f7a991705f9707d31285
https://doi.org/10.18499/2225-7357-2016-5-3-84-89
https://doi.org/10.18499/2225-7357-2016-5-3-84-89
Publikováno v:
Journal of Ural Medical Academic Science. :61-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7183e473f6ae37fd102ccb4ffa39ad6c
https://doi.org/10.22138/2500-0918-2016-15-3-61-74
https://doi.org/10.22138/2500-0918-2016-15-3-61-74
Autor:
S. Ramalingam, J. Crawford, A. Chang, C. Manegold, R. Perez-Soler, J.-Y. Douillard, N. Thatcher, F. Barlesi, T. Owonikoko, Y. Wang, P. Pultar, J. Zhu, R. Malik, G. Giaccone, S. Della-Fiorentina, S. Begbie, R. Jennens, J. Dass, K. Pittman, N. Ivanova, T. Koynova, P. Petrov, A. Tomova, V. Tzekova, F. Couture, V. Hirsh, R. Burkes, R. Sangha, M. Ambrus, T. Janaskova, J. Musil, J. Novotny, P. Zatloukal, J. Jakesova, K. Klenha, J. Roubec, J. Vanasek, J. Fayette, J. Bennouna-Louridi, C. Chouaid, J. Mazières, H. Vallerand, G. Robinet, P.-J. Souquet, D. Spaeth, R. Schott, H. Lena, Y. Martinet, C. El Kouri, N. Baize, A. Scherpereel, O. Molinier, F. Fuchs, K.M. Josten, N. Marschner, F. Schneller, T. Overbeck, M. Thomas, J. von Pawel, M. Reck, W. Schuette, V. Hagen, C.-P. Schneider, V. Georgoulias, I. Varthalitis, K. Zarogoulidis, K. Syrigos, C. Papandreou, C. Bocskei, E. Csanky, E. Juhasz, G. Losonczy, Z. Mark, I. Molnar, Z. Papai-Szekely, S. Tehenes, I. Vinkler, S. Almel, A. Bakshi, S. Bondarde, A. Maru, A. Pathak, R.M. Pedapenki, K. Prasad, S.V.S.S. Prasad, N. Kilara, D. Gorijavolu, C.D. Deshmukh, S. John, L.M. Sharma, D. Amoroso, E. Bajetta, P. Bidoli, A. Bonetti, F. De Marinis, M. Maio, R. Passalacqua, S. Cascinu, A. Bearz, M. Bitina, A. Brize, G. Purkalne, M. Skrodele, A.A. Baba, K. Ratnavelu, M.H. Saw, M.C. Samson-Fernando, G.E. Ladrera, J. Jassem, P. Koralewski, P. Serwatowski, M. Krzakowski, C. Cebotaru, D. Filip, D.E. Ganea-Motan, C.H. Ianuli, I.G. Manolescu, A. Udrea, O. Burdaeva, M. Byakhov, A. Filippov, S. Lazarev, I. Mosin, S. Orlov, D. Udovitsa, A. Khorinko, S. Protsenko, H.L. Lim, Y.O. Tan, E.H. Tan, R. Bastus Piulats, J. Garcia-Foncillas, J. Valdivia, J. de Castro, M. Domine Gomez, S.W. Kim, J.-S. Lee, H.K. Kim, J.S. Lee, S.W. Shin, D.-W. Kim, Y.-C. Kim, K.C. Park, C.-S. Chang, G.-C. Chang, Y.-G. Goan, W.-C. Su, C.-M. Tsai, H.-P. Kuo, M. Benekli, G. Demir, E. Gokmen, A. Sevinc, M. Haigentz, M. Agarwal, S. Pandit, R. Araujo, N. Vrindavanam, P. Bonomi, A. Berg, J. Wade, R. Bloom, B. Amin, R. Camidge, D. Hill, M. Rarick, P. Flynn, L. Klein, K. Lo Russo, M. Neubauer, P. Richards, R. Ruxer, M. Savin, D. Weckstein, R. Rosenberg, T. Whittaker, D. Richards, W. Berry, C. Ottensmeier, A. Dangoor, N. Steele, Y. Summers, E. Rankin, K. Rowley, S. Giridharan, H. Kristeleit, C. Humber, P. Taylor
Publikováno v:
Annals of Oncology. 24:2875-2880
Background Talactoferrin alfa is an oral dendritic cell (DC)-mediated immunotherapy (DCMI). We tested whether talactoferrin was superior to placebo in advanced non-small-cell lung cancer (NSCLC). Patients and methods An FORTIS-M trial was an internat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::279f128904fe8fc09b31972c2bf65519
https://doi.org/10.1093/annonc/mdt371
https://doi.org/10.1093/annonc/mdt371